IRIDEX Corporation
Every calculator, already run for IRIX
Open the full toolkit →You have the numbers on IRIX. Get the argument.
A written report on which of these readings actually decide the outcome for IRIDEX Corporation, what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
1 analysts covering IRIXOwnership & short interest
Insider Trading Activity for IRIX
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About IRIDEX Corporation
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including slit lamp adapter, which allows the physic…
IRIX — frequently asked
Is IRIX a buy right now?
Wall Street's consensus rating on IRIDEX Corporation is none across 1 analysts, with a mean price target of $2.75 (+310% vs. the current $0.67). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is IRIX overvalued?
IRIX trades at — trailing earnings, against a DCF fair value of $3 per share. The current price implies -10% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is IRIX's next earnings date?
IRIDEX Corporation is next scheduled to report earnings around Nov 17, 2026. A full IRIX research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
Compare IRIDEX Corporation against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For IRIDEX Corporation
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full IRIX research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on IRIDEX Corporation, in minutes. 3 free reports included with every account — no credit card required.